Two GV partners on biotech’s reset and building their next drug startups
Newly named partner Anthony Philippakis and managing partner Krishna Yeshwant spoke with BioPharma Dive about biotech’s newfound optimism and their investing “North Star.”
Newly named partner Anthony Philippakis and managing partner Krishna Yeshwant spoke with BioPharma Dive about biotech’s newfound optimism and their investing “North Star.”
AcuteCVDays, brought to you by the Association for Acute Cardiovascular Care (ACVC), facilitates learning and discussing potential differences between North America and Europe in the…
The approval marks the return of the dissolving-scaffold concept, which so far has failed to find success in the coronaries.
Show Pediheart: Pediatric Cardiology Today, Ep Pediheart Podcast #295: Right Atrial Thrombus Post Gore Cardioform ASD Closure – Reason For Concern? – May 2, 2024
A dry desert wind blew into the mouth of Bizmoune Cave on the flank of a limestone mountain in western Morocco. Last November, two students…
AbstractAims. Over time, cardiovascular disease (CVD) deaths increasingly exceed those from malignancy among cancer survivors. However, the association of
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by…
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by…
The Edwin Bierman Award Lecture is presented in honor of the memory of Edwin L. Bierman, MD, an exemplary scientist, mentor, and leader in the…
Vinay K. Bhal and Mamas Mamas discuss the distinct precursors, epidemiology, and care of valvular heart disease in India.
AbstractBackground and Aims. Patients undergoing revascularization for lower extremity arterial disease (LEAD) may face a higher risk of mortality than tho